Article
Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy.
International journal of cardiology - 15 Oct 2023
Neves Raquel, Tseng Andrew S, Garmany Ramin, Fink Angela L, McLeod Christopher J, Cooper Leslie T, MacIntyre Ciorsti J, Homb Andrew C, Rosenbaum Andrew N, Bois John P, Abou Ezzeddine Omar F, Siontis Konstantinos C, Pereira Naveen L, Ackerman Michael J, Giudicessi John R
Abstract excerpt
BACKGROUND: Myocardial inflammation contributes to the pathogenesis of arrhythmogenic cardiomyopathy (ACM), a clinically and genetically heterogenous disorder. Due to phenotypic overlap, some patients with genetic ACM may be evaluated for an underlying inflammatory cardiomyopathy. However, the cardiac fludeoxyglucose (FDG) positron emission tomography (PET) findings in ACM patients have not been elucidated....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.